Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about press release

06 Jul 2022 Evaluate
Aurobindo Pharma has informed that it enclosed Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities, a wholly owned subsidiary of the Company, for Triamcinolone Acetonide Injectable Suspension.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1838.00
Dr. Reddys Labs. 1354.65
Cipla 1373.90
Lupin 2011.60
Zydus Lifesciences 1239.10
View more..